Percutaneous coronary intervention increases leptin and decreases adiponectin levels

Clinical Endocrinology

Volumn 65, Issue 6, 2006, Pages 712-716

  Azar, Rabih R ^a   Sarkis, Antoine ^a   Salameh, Elie ^a   Gannagé Yared, Marie Hélène ^a   Amm Azar, Mireille ^a   Badaoui, Georges ^a   Germanos, Mirna ^a   Kassab, Roland ^a  

^a SAINT JOSEPH UNIVERSITY   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; INTERLEUKIN 6; LEPTIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; HUMAN; INFLAMMATION; MALE; PATHOGENESIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADIPONECTIN; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY DISEASE; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; LEPTIN; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 33751085371     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02654.x     Document Type: Article

References (39)

1. Flegal, K.M., Carroll, M.D., Ogden, C.L. & Johnson, C.L. (2002) Prevalence and trends in obesity among US adults, 1999-2000. Journal of the American Medical Association, 288, 1723-1727.
2. Lakka, H.M., Laaksonen, D.E., Lakka, T.A., Niskanen, L.K., Kumpusalo, E., Tuomilehto, J. & Salonene, J.T. (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. Journal of the American Medical Association, 288, 2709-2716.
3. Kahn, B.B. & Flier, J.S. (2000) Obesity and insulin resistance. Journal of Clinical Investigation, 106, 473-481.
4. Maison, P., Byrne, C.D., Hales, C.N., Day, N.E. & Wareham, N.J. (2001) Do different dimensions of the metabolic syndrome change together over time? Evidence supporting obesity as the central feature. Diabetes Care, 24, 1758-1763.
5. Ridker, P.M., Cushman, M., Stampfer, M.J., Tracy, R.P. & Hennekens, C.H. (1997) Inflammation, aspirin, and risks of cardiovascular disease in apparently healthy men. New England Journal of Medicine, 336, 973-979.
6. Han, T.S., Sattar, N., Williams, K., Gonzalez-Villalpando, C., Lean, M.E. & Haffner, S.M. (2002) Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care, 25, 2016-2021.
7. Sattar, N., Gaw, A., Scherbakova, O., Ford, I., O'Reilly, D.S., Haffner, S.M., Isles, C., Macfarlene, P.W., Packard, C.J., Cobbe, S.M. & Shepherd, J. (2003) Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation, 108, 414-419.
8. Rutter, M.K., Meigs, J.B., Sullivan, L.M., D'Agostino, R.B. & Wilson, P.W.F. (2004) C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham offspring study. Circulation, 110, 380-385.
9. Bastard, J.P., Jardel, C., Delattre, J., Hainque, B., Bruckert, E. & Oberlin, F. (1999) Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects. Circulation, 99, 2221-2222.
10. Bistrian, B.R. & Khaodhiar, L. (2000) Chronic systemic inflammation in overweight and obese adults. Journal of the American Medical Association, 283, 2235-2236.
11. Ghanim, H., Aljada, A., Hofmeyer, D., Syed, T., Mohanty, P. & Dandona, P. (2004) Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation, 110, 1564-1571.
12. Hu, F.B., Meigs, J.B., Li, T.Y., Rifai, N. & Manson, J.E. (2004) Inflammatory markers and risk of developing type-2 diabetes in women. Diabetes, 53, 693-700.
13. Pradhan, A.D., Manson, J.E., Rifai, N., Buring, J.E. & Ridker, P.M. (2001) C-reactive protein, interleukin-6, and risk of developing type 2 diabetes mellitus. Journal of the American Medical Association, 286, 327-334.
14. Helmersson, J., Vessby, B., Larsson, A. & Basu, S. (2004) Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population. Circulation, 109, 1729-1734.
15. Yudkin, J.S., Stehouwer, C.D., Emeis, J.J. & Coppack, S.W. (1999) C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction. A potential role for cytokines originating from adipose tissue? Arteriosclerosis, Thrombosis and Vascular Biology, 19, 972-978.
16. Kershaw, E.E. & Flier, J.S. (2004) Adipose tissue as an endocrine organ. Journal of Clinical Endocrinology and Metabolism, 89, 2548-2556.
17. Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R.E. & Tataranni, P.A. (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism, 86, 1930-1935.
18. Kumada, M., Kihara, S., Sumitsuji, S., Kawamoto, T., Matsumoto, S., Ouchi, N., Arita, Y., Okamoto, Y., Shimomura, Y., Hiraoka, H., Nakamura, T., Funahashi, T. & Matsuzawa, Y. (2003) Association of hypoadiponectinemia with coronary artery disease in men. Arteriosclerosis, Thrombosis and Vascular Biology, 23, 85-89.
19. Pischon, T., Girman, C.J., Hotamisligil, G.S., Rifai, N., Hu, F.B. & Rimm, E.B. (2004) Plasma adiponectin levels and risk of myocardial infarction in men. Journal of the American Medical Association, 291, 1730-1737.
20. Sader, S., Nian, M. & Liu, P. (2003) Leptin: a novel link between obesity, diabetes, cardiovascular risk, and ventricular hypertrophy. Circulation, 108, 644-646.
21. Leyva, F., Godsland, I.F., Ghatei, M., Proudler, A.J., Aldis, S., Walton, C., Bloom, S. & Stevenson, J.C. (1998) Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arteriosclerosis, Thrombosis and Vascular Biology, 18, 928-933.
22. Wallace, A.M., McMahon, A.D., Packard, C.J., Kelly, A., Shepherd, J., Gaw, A. & Sattar, N. (2001) Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation, 104, 3052-3056.
23. Azar, R.R., McKay, R.G., Kiernan, F.J., Seecharran, B., Feng, Y.J., Fram, D.B., Wu, A.H. & Waters, D.D. (1997) Coronary angioplasty induces a systemic inflammatory response. American Journal of Cardiology, 80, 1476-1478.
24. Azar, R.R., Badaoui, G., Sarkis, A., Kassab, R., Salamé, E., Klaymé, S., Naman, R. & Germanos, R. (2005) Effects of tirofiban and statins on markers of inflammation and platelets activation following percutaneous coronary interventions in patients with stable coronary artery disease. American Journal of Cardiology, 95, 236-240.
25. Baumann, H., Morella, K.K., White, D.W., Dembski, M., Bailon, P.S., Kim, H., Lai, C.F. & Tartaglia, L.A. (1996) The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proceedings of the National Academy of Sciences of the United States of America, 93, 8374-8378.
26. Loffreda, S., Yang, S.Q., Lin, H.Z., Karp, C.L., Brengman, M.L., Wang, D.J., Klein, A.S., Bulkley, G.B., Bao, C., Noble, P.W., Lane, M.D. & Diehl, A.M. (1998) Leptin regulates proinflammatory immune responses. FASEB Journal, 12, 57-65.
27. Bruun, J.M., Lihn, A.S., Verdich, C., Pedersen, S.B., Toubro, S., Astrup, A. & Richelsen, B. (2003) Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. American Journal of Physiology. Endocrinology and Metabolism, 285, E527-E533.
28. Fasshauer, M., Kralisch, S., Klier, M., Lossner, U., Bluher, M., Klein, J. & Paschke, R. (2003) Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications, 301, 1045-1050.
29. Vivekananthan, D.P., Bhatt, D.L., Chew, D.P., Zidar, F.J., Chan, A.W., Moliterno, D.J., Ellis, S.G. & Topol, E.J. (2004) Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary intervention. American Journal of Cardiology, 94, 358-360.
30. Mohamed-Ali, V., Goodrick, S., Rawesh, A., Katz, D.R., Miles, J.M., Yudkin, J.S., Klein, S. & Coppack, S.W. (1997) Subcutaneous adipose tissue releases interleukin-6, but not tumour necrosis factoralpha, in vivo. Journal of Clinical Endocrinology and Metabolism, 82, 4196-4200.
31. Senn, J.J., Klover, P.J., Nowak, I.A., Zimmers, T.A., Koniaris, L.G., Furlanetto, R.W. & Mooney, R.A. (2003) Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. Journal of Biological Chemistry, 278, 13740-13746.
32. Goldstein, B.J. & Scalia, R. (2004) Adiponectin: a novel adipokine linking adipocytes and vascular function. Journal of Clinical Endocrinology and Metabolism, 89, 2563-2568.
33. Diez, J.J. & Iglesias, P. (2003) The role of the novel adipocyte-derived hormone adiponectin in human disease. European Journal of Endocrinology, 148, 293-300.
34. Ouchi, N., Kihara, S., Arita, Y., Maeda, K., Kuriyama, H., Okamoto, Y., Hotta, K., Nishida, M., Takahashi, M., Nakamura, T., Yamashita, S., Funahashi, T. & Matsuzawa, Y. (1999) Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation, 100, 2473-2476.
35. Kumada, M., Kihara, S., Ouchi, N., Kobayashi, H., Okamoto, Y., Ohashi, K., Maeda, K., Nagaretani, H., Kishida, K., Maeda, N., Nagasawa, A., Funahashi, T. & Matsuzawa, Y. (2004) Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation, 109, 2046-2049.
36. Schafer, K., Halle, M., Goeschen, C., Dellas, C., Pynn, M., Loskutoff, D.J. & Konstantinides, S. (2004) Leptin promotes vascular remodeling and neointimal growth in mice. Arteriosclerosis, Thrombosis and Vascular Biology, 24, 112-117.
37. Shek, E.W., Brands, M.W. & Hall, J.E. (1998) Chronic leptin infusion increases arterial pressure. Hypertension, 31, 409-414.
38. Konstantinides, S., Schafer, K., Koschnick, S. & Loskutoff, D.J. (2001) Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. Journal of Clinical Investigation, 108, 1533-1540.
39. Berg, K., Wiseth, R., Bjerve, K., Brurok, H., Gunnes, S., Skarra, S., Jynge, P. & Basu, S. (2004) Oxidative stress and myocardial damage during elective percutaneous coronary interventions and coronary angiography. A comparison of blood-borne isoprostane and troponin release. Free Radical Research, 38, 517-525.